Outcomes of CEM43 in Predicting Thermal Damage Induced by Focal Laser Ablation in Controlled Ex Vivo Experiments: A Comparison to Histology and MRI

ABSTRACT Background Focal laser ablation (FLA) serves as a targeted therapy for prostate cancer (PCa). Clinical studies have demonstrated significant variations in ablation volumes with consistent fiber configurations. Consequently, a prediction model is needed for the safe application of FLA in tre...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Lasers in surgery and medicine 2024-10, Vol.56 (8), p.723-733
Hauptverfasser: Bie, K. C. C., Kollenburg, R. A. A., Riel, L. A. M. J. G., Almasian, M., Freund, J. E., Bloemen, P. R., Zweije, R., Crezee, J., Coolen, B. F., Strijkers, G. J., Reijke, T. M., Oddens, J. R., Leeuwen, A. G. J. M., Bruin, D. M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 733
container_issue 8
container_start_page 723
container_title Lasers in surgery and medicine
container_volume 56
creator Bie, K. C. C.
Kollenburg, R. A. A.
Riel, L. A. M. J. G.
Almasian, M.
Freund, J. E.
Bloemen, P. R.
Zweije, R.
Crezee, J.
Coolen, B. F.
Strijkers, G. J.
Reijke, T. M.
Oddens, J. R.
Leeuwen, A. G. J. M.
Bruin, D. M.
description ABSTRACT Background Focal laser ablation (FLA) serves as a targeted therapy for prostate cancer (PCa). Clinical studies have demonstrated significant variations in ablation volumes with consistent fiber configurations. Consequently, a prediction model is needed for the safe application of FLA in treating PCa. Objective This study aimed to evaluate the reproducibility of FLA–induced temperature profiles in controlled ex vivo experiments using clinical laser treatment protocols. Additionally, it sought to examine the effectiveness of the CEM43 model in predicting the zone of irreversible damage (ZID) and to compare these findings with outcomes derived from the Arrhenius model. Methods Freshly excised postmortem human prostate and porcine liver specimens were used for controlled ex vivo ablation. Tissues were secured in a Perspex sample holder for precise placement of the laser fiber and thermocouples. FLA was conducted with a 1064‐nm Nd:YAG laser at 3 W in continuous‐wave mode for 10 min. Pre– and post–FLA 3D T1‐weighted 7 T MRI scans were obtained to assess the treatment area. Whole‐mount hematoxylin and eosin histological slides were prepared and digitized. On histology, the ZID was defined as the total of vaporized, carbonized, and coagulated tissue. A 2D thermal development map was created from temperature data, using bi‐cubic interpolation. The cumulative equivalent thermal isoeffect dose at 43°C in minutes (CEM43) model was applied to predict the ZID, with 240 equivalent minutes (240‐CEM43) used as the damage threshold. Additionally, the Arrhenius thermal model was used for comparison of CEM43 results. Predicted ZIDs were compared to MRI and histology. Results FLA treatment was performed on ex vivo human prostate samples (n = 2) and porcine liver specimens (n = 5). For human prostate tissue, FLA did not result in an identifiable ZID upon histological macroscopic examination or a lesion on MRI. Ex vivo porcine liver samples showed a clearly demarcated oval‐shaped hyperintense lesion surrounding the laser fiber tip on post–FLA MRI. The MRI lesion (range 1.6–2.1 cm2) corresponded with the shape and location of the ZID on histology, but was smaller (median 1.7 vs. 3.2, p = 0.02). Histological examination of porcine liver samples revealed ZIDs ranging from 2.1 to 4.1 cm2, whereas 240‐CEM43–predicted ZIDs ranged from 3.3 to 3.8 cm2. Although the median 240‐CEM43–predicted ZID was not significantly larger than the histology ZID (3.8 vs. 3.2 cm2, p = 0.22), it
doi_str_mv 10.1002/lsm.23834
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3096281615</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3108519010</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3484-b8c9f5332b6be33508fce46840d3a81d7163560f333210fba72bd5d9ac4f26f83</originalsourceid><addsrcrecordid>eNp10ctOGzEUBmALFUFKWfQFKkvdlEXgeDwz8bCL0lAiJaIql63l8SUYeezUninNc_SFaxpggdTVsazPv2z_CH0kcEoAijOXutOCMlruoRGBph43BMg7NAKS1wya4hC9T-kBAGgBkwN0SBsyqUjFRujP1dDL0OmEg8Gz-aqk2Hr8PWplZW_9Gt_c69gJh7-KTqw1Xng1SK1wu8UXQeb9pUg64mnrRG-Dfzo8C76Pwbms5r_xnf0V8tzoaDvt-3SOp1l0GxFtyr4P-NKmPriw3mLhFV79WHxA-0a4pI-f5xG6vZjfzC7Hy6tvi9l0OZa0ZOW4ZbIxFaVFW7ea0gqYkbqsWQmKCkbUhNS0qsHQTAiYVkyKVlWqEbI0RW0YPUJfdrmbGH4OOvW8s0lq54TXYUic5q8sGKlJlennN_QhDNHn23FKgFWkAQJZneyUjCGlqA3f5FeLuOUE-FNTPDfF_zWV7afnxKHttHqVL9VkcLYDj9bp7f-T-PJ6tYv8C_Jnm68</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3108519010</pqid></control><display><type>article</type><title>Outcomes of CEM43 in Predicting Thermal Damage Induced by Focal Laser Ablation in Controlled Ex Vivo Experiments: A Comparison to Histology and MRI</title><source>Wiley Online Library Journals</source><creator>Bie, K. C. C. ; Kollenburg, R. A. A. ; Riel, L. A. M. J. G. ; Almasian, M. ; Freund, J. E. ; Bloemen, P. R. ; Zweije, R. ; Crezee, J. ; Coolen, B. F. ; Strijkers, G. J. ; Reijke, T. M. ; Oddens, J. R. ; Leeuwen, A. G. J. M. ; Bruin, D. M.</creator><creatorcontrib>Bie, K. C. C. ; Kollenburg, R. A. A. ; Riel, L. A. M. J. G. ; Almasian, M. ; Freund, J. E. ; Bloemen, P. R. ; Zweije, R. ; Crezee, J. ; Coolen, B. F. ; Strijkers, G. J. ; Reijke, T. M. ; Oddens, J. R. ; Leeuwen, A. G. J. M. ; Bruin, D. M.</creatorcontrib><description>ABSTRACT Background Focal laser ablation (FLA) serves as a targeted therapy for prostate cancer (PCa). Clinical studies have demonstrated significant variations in ablation volumes with consistent fiber configurations. Consequently, a prediction model is needed for the safe application of FLA in treating PCa. Objective This study aimed to evaluate the reproducibility of FLA–induced temperature profiles in controlled ex vivo experiments using clinical laser treatment protocols. Additionally, it sought to examine the effectiveness of the CEM43 model in predicting the zone of irreversible damage (ZID) and to compare these findings with outcomes derived from the Arrhenius model. Methods Freshly excised postmortem human prostate and porcine liver specimens were used for controlled ex vivo ablation. Tissues were secured in a Perspex sample holder for precise placement of the laser fiber and thermocouples. FLA was conducted with a 1064‐nm Nd:YAG laser at 3 W in continuous‐wave mode for 10 min. Pre– and post–FLA 3D T1‐weighted 7 T MRI scans were obtained to assess the treatment area. Whole‐mount hematoxylin and eosin histological slides were prepared and digitized. On histology, the ZID was defined as the total of vaporized, carbonized, and coagulated tissue. A 2D thermal development map was created from temperature data, using bi‐cubic interpolation. The cumulative equivalent thermal isoeffect dose at 43°C in minutes (CEM43) model was applied to predict the ZID, with 240 equivalent minutes (240‐CEM43) used as the damage threshold. Additionally, the Arrhenius thermal model was used for comparison of CEM43 results. Predicted ZIDs were compared to MRI and histology. Results FLA treatment was performed on ex vivo human prostate samples (n = 2) and porcine liver specimens (n = 5). For human prostate tissue, FLA did not result in an identifiable ZID upon histological macroscopic examination or a lesion on MRI. Ex vivo porcine liver samples showed a clearly demarcated oval‐shaped hyperintense lesion surrounding the laser fiber tip on post–FLA MRI. The MRI lesion (range 1.6–2.1 cm2) corresponded with the shape and location of the ZID on histology, but was smaller (median 1.7 vs. 3.2, p = 0.02). Histological examination of porcine liver samples revealed ZIDs ranging from 2.1 to 4.1 cm2, whereas 240‐CEM43–predicted ZIDs ranged from 3.3 to 3.8 cm2. Although the median 240‐CEM43–predicted ZID was not significantly larger than the histology ZID (3.8 vs. 3.2 cm2, p = 0.22), it tended to overpredict the histological results in most experiments. The median Arrhenius‐predicted ZID was similar to the histological ZID (3.2 vs. 3.2 cm2, p = 0.56), but varied in size when comparing individual experiments (range 2.5–3.2 cm2). Conclusion FLA on ex vivo human prostate showed no thermal damage on histopathology or MRI. Ex vivo porcine liver FLA resulted in identifiable ZID on histology and lesions on MRI. 240‐CEM43 generally overestimated the ZID and had less variability compared to histology. Results from the Arrhenius model were in better agreement with the histology findings, but still did not predict the individual FLA–induced histological thermal damage. Inter‐experiment ZID variability underlines the need for developing a more comprehensive predictive dosimetry model for FLA in PCa treatment.</description><identifier>ISSN: 0196-8092</identifier><identifier>ISSN: 1096-9101</identifier><identifier>EISSN: 1096-9101</identifier><identifier>DOI: 10.1002/lsm.23834</identifier><identifier>PMID: 39175158</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>Ablation ; CEM43 ; Continuous fibers ; Damage detection ; Dosimetry ; Equivalence ; Experiments ; focal laser ablation ; Histology ; Human performance ; Laser ablation ; Laser damage ; Lasers ; Lesions ; Liver ; Magnetic resonance imaging ; Neodymium lasers ; Prediction models ; Predictive control ; Prostate ; Prostate cancer ; Sample holders ; Semiconductor lasers ; Temperature profiles ; Thermal analysis ; thermal‐dose threshold ; Thermocouples ; YAG lasers ; Yield point</subject><ispartof>Lasers in surgery and medicine, 2024-10, Vol.56 (8), p.723-733</ispartof><rights>2024 The Author(s). published by Wiley Periodicals LLC.</rights><rights>2024 The Author(s). Lasers in Surgery and Medicine published by Wiley Periodicals LLC.</rights><rights>2024. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3484-b8c9f5332b6be33508fce46840d3a81d7163560f333210fba72bd5d9ac4f26f83</cites><orcidid>0000-0001-5759-3909 ; 0000-0002-6892-8943</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Flsm.23834$$EPDF$$P50$$Gwiley$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Flsm.23834$$EHTML$$P50$$Gwiley$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39175158$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bie, K. C. C.</creatorcontrib><creatorcontrib>Kollenburg, R. A. A.</creatorcontrib><creatorcontrib>Riel, L. A. M. J. G.</creatorcontrib><creatorcontrib>Almasian, M.</creatorcontrib><creatorcontrib>Freund, J. E.</creatorcontrib><creatorcontrib>Bloemen, P. R.</creatorcontrib><creatorcontrib>Zweije, R.</creatorcontrib><creatorcontrib>Crezee, J.</creatorcontrib><creatorcontrib>Coolen, B. F.</creatorcontrib><creatorcontrib>Strijkers, G. J.</creatorcontrib><creatorcontrib>Reijke, T. M.</creatorcontrib><creatorcontrib>Oddens, J. R.</creatorcontrib><creatorcontrib>Leeuwen, A. G. J. M.</creatorcontrib><creatorcontrib>Bruin, D. M.</creatorcontrib><title>Outcomes of CEM43 in Predicting Thermal Damage Induced by Focal Laser Ablation in Controlled Ex Vivo Experiments: A Comparison to Histology and MRI</title><title>Lasers in surgery and medicine</title><addtitle>Lasers Surg Med</addtitle><description>ABSTRACT Background Focal laser ablation (FLA) serves as a targeted therapy for prostate cancer (PCa). Clinical studies have demonstrated significant variations in ablation volumes with consistent fiber configurations. Consequently, a prediction model is needed for the safe application of FLA in treating PCa. Objective This study aimed to evaluate the reproducibility of FLA–induced temperature profiles in controlled ex vivo experiments using clinical laser treatment protocols. Additionally, it sought to examine the effectiveness of the CEM43 model in predicting the zone of irreversible damage (ZID) and to compare these findings with outcomes derived from the Arrhenius model. Methods Freshly excised postmortem human prostate and porcine liver specimens were used for controlled ex vivo ablation. Tissues were secured in a Perspex sample holder for precise placement of the laser fiber and thermocouples. FLA was conducted with a 1064‐nm Nd:YAG laser at 3 W in continuous‐wave mode for 10 min. Pre– and post–FLA 3D T1‐weighted 7 T MRI scans were obtained to assess the treatment area. Whole‐mount hematoxylin and eosin histological slides were prepared and digitized. On histology, the ZID was defined as the total of vaporized, carbonized, and coagulated tissue. A 2D thermal development map was created from temperature data, using bi‐cubic interpolation. The cumulative equivalent thermal isoeffect dose at 43°C in minutes (CEM43) model was applied to predict the ZID, with 240 equivalent minutes (240‐CEM43) used as the damage threshold. Additionally, the Arrhenius thermal model was used for comparison of CEM43 results. Predicted ZIDs were compared to MRI and histology. Results FLA treatment was performed on ex vivo human prostate samples (n = 2) and porcine liver specimens (n = 5). For human prostate tissue, FLA did not result in an identifiable ZID upon histological macroscopic examination or a lesion on MRI. Ex vivo porcine liver samples showed a clearly demarcated oval‐shaped hyperintense lesion surrounding the laser fiber tip on post–FLA MRI. The MRI lesion (range 1.6–2.1 cm2) corresponded with the shape and location of the ZID on histology, but was smaller (median 1.7 vs. 3.2, p = 0.02). Histological examination of porcine liver samples revealed ZIDs ranging from 2.1 to 4.1 cm2, whereas 240‐CEM43–predicted ZIDs ranged from 3.3 to 3.8 cm2. Although the median 240‐CEM43–predicted ZID was not significantly larger than the histology ZID (3.8 vs. 3.2 cm2, p = 0.22), it tended to overpredict the histological results in most experiments. The median Arrhenius‐predicted ZID was similar to the histological ZID (3.2 vs. 3.2 cm2, p = 0.56), but varied in size when comparing individual experiments (range 2.5–3.2 cm2). Conclusion FLA on ex vivo human prostate showed no thermal damage on histopathology or MRI. Ex vivo porcine liver FLA resulted in identifiable ZID on histology and lesions on MRI. 240‐CEM43 generally overestimated the ZID and had less variability compared to histology. Results from the Arrhenius model were in better agreement with the histology findings, but still did not predict the individual FLA–induced histological thermal damage. Inter‐experiment ZID variability underlines the need for developing a more comprehensive predictive dosimetry model for FLA in PCa treatment.</description><subject>Ablation</subject><subject>CEM43</subject><subject>Continuous fibers</subject><subject>Damage detection</subject><subject>Dosimetry</subject><subject>Equivalence</subject><subject>Experiments</subject><subject>focal laser ablation</subject><subject>Histology</subject><subject>Human performance</subject><subject>Laser ablation</subject><subject>Laser damage</subject><subject>Lasers</subject><subject>Lesions</subject><subject>Liver</subject><subject>Magnetic resonance imaging</subject><subject>Neodymium lasers</subject><subject>Prediction models</subject><subject>Predictive control</subject><subject>Prostate</subject><subject>Prostate cancer</subject><subject>Sample holders</subject><subject>Semiconductor lasers</subject><subject>Temperature profiles</subject><subject>Thermal analysis</subject><subject>thermal‐dose threshold</subject><subject>Thermocouples</subject><subject>YAG lasers</subject><subject>Yield point</subject><issn>0196-8092</issn><issn>1096-9101</issn><issn>1096-9101</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><recordid>eNp10ctOGzEUBmALFUFKWfQFKkvdlEXgeDwz8bCL0lAiJaIql63l8SUYeezUninNc_SFaxpggdTVsazPv2z_CH0kcEoAijOXutOCMlruoRGBph43BMg7NAKS1wya4hC9T-kBAGgBkwN0SBsyqUjFRujP1dDL0OmEg8Gz-aqk2Hr8PWplZW_9Gt_c69gJh7-KTqw1Xng1SK1wu8UXQeb9pUg64mnrRG-Dfzo8C76Pwbms5r_xnf0V8tzoaDvt-3SOp1l0GxFtyr4P-NKmPriw3mLhFV79WHxA-0a4pI-f5xG6vZjfzC7Hy6tvi9l0OZa0ZOW4ZbIxFaVFW7ea0gqYkbqsWQmKCkbUhNS0qsHQTAiYVkyKVlWqEbI0RW0YPUJfdrmbGH4OOvW8s0lq54TXYUic5q8sGKlJlennN_QhDNHn23FKgFWkAQJZneyUjCGlqA3f5FeLuOUE-FNTPDfF_zWV7afnxKHttHqVL9VkcLYDj9bp7f-T-PJ6tYv8C_Jnm68</recordid><startdate>202410</startdate><enddate>202410</enddate><creator>Bie, K. C. C.</creator><creator>Kollenburg, R. A. A.</creator><creator>Riel, L. A. M. J. G.</creator><creator>Almasian, M.</creator><creator>Freund, J. E.</creator><creator>Bloemen, P. R.</creator><creator>Zweije, R.</creator><creator>Crezee, J.</creator><creator>Coolen, B. F.</creator><creator>Strijkers, G. J.</creator><creator>Reijke, T. M.</creator><creator>Oddens, J. R.</creator><creator>Leeuwen, A. G. J. M.</creator><creator>Bruin, D. M.</creator><general>Wiley Subscription Services, Inc</general><scope>24P</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>M7Z</scope><scope>P64</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-5759-3909</orcidid><orcidid>https://orcid.org/0000-0002-6892-8943</orcidid></search><sort><creationdate>202410</creationdate><title>Outcomes of CEM43 in Predicting Thermal Damage Induced by Focal Laser Ablation in Controlled Ex Vivo Experiments: A Comparison to Histology and MRI</title><author>Bie, K. C. C. ; Kollenburg, R. A. A. ; Riel, L. A. M. J. G. ; Almasian, M. ; Freund, J. E. ; Bloemen, P. R. ; Zweije, R. ; Crezee, J. ; Coolen, B. F. ; Strijkers, G. J. ; Reijke, T. M. ; Oddens, J. R. ; Leeuwen, A. G. J. M. ; Bruin, D. M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3484-b8c9f5332b6be33508fce46840d3a81d7163560f333210fba72bd5d9ac4f26f83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Ablation</topic><topic>CEM43</topic><topic>Continuous fibers</topic><topic>Damage detection</topic><topic>Dosimetry</topic><topic>Equivalence</topic><topic>Experiments</topic><topic>focal laser ablation</topic><topic>Histology</topic><topic>Human performance</topic><topic>Laser ablation</topic><topic>Laser damage</topic><topic>Lasers</topic><topic>Lesions</topic><topic>Liver</topic><topic>Magnetic resonance imaging</topic><topic>Neodymium lasers</topic><topic>Prediction models</topic><topic>Predictive control</topic><topic>Prostate</topic><topic>Prostate cancer</topic><topic>Sample holders</topic><topic>Semiconductor lasers</topic><topic>Temperature profiles</topic><topic>Thermal analysis</topic><topic>thermal‐dose threshold</topic><topic>Thermocouples</topic><topic>YAG lasers</topic><topic>Yield point</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bie, K. C. C.</creatorcontrib><creatorcontrib>Kollenburg, R. A. A.</creatorcontrib><creatorcontrib>Riel, L. A. M. J. G.</creatorcontrib><creatorcontrib>Almasian, M.</creatorcontrib><creatorcontrib>Freund, J. E.</creatorcontrib><creatorcontrib>Bloemen, P. R.</creatorcontrib><creatorcontrib>Zweije, R.</creatorcontrib><creatorcontrib>Crezee, J.</creatorcontrib><creatorcontrib>Coolen, B. F.</creatorcontrib><creatorcontrib>Strijkers, G. J.</creatorcontrib><creatorcontrib>Reijke, T. M.</creatorcontrib><creatorcontrib>Oddens, J. R.</creatorcontrib><creatorcontrib>Leeuwen, A. G. J. M.</creatorcontrib><creatorcontrib>Bruin, D. M.</creatorcontrib><collection>Wiley Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biochemistry Abstracts 1</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Lasers in surgery and medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bie, K. C. C.</au><au>Kollenburg, R. A. A.</au><au>Riel, L. A. M. J. G.</au><au>Almasian, M.</au><au>Freund, J. E.</au><au>Bloemen, P. R.</au><au>Zweije, R.</au><au>Crezee, J.</au><au>Coolen, B. F.</au><au>Strijkers, G. J.</au><au>Reijke, T. M.</au><au>Oddens, J. R.</au><au>Leeuwen, A. G. J. M.</au><au>Bruin, D. M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Outcomes of CEM43 in Predicting Thermal Damage Induced by Focal Laser Ablation in Controlled Ex Vivo Experiments: A Comparison to Histology and MRI</atitle><jtitle>Lasers in surgery and medicine</jtitle><addtitle>Lasers Surg Med</addtitle><date>2024-10</date><risdate>2024</risdate><volume>56</volume><issue>8</issue><spage>723</spage><epage>733</epage><pages>723-733</pages><issn>0196-8092</issn><issn>1096-9101</issn><eissn>1096-9101</eissn><abstract>ABSTRACT Background Focal laser ablation (FLA) serves as a targeted therapy for prostate cancer (PCa). Clinical studies have demonstrated significant variations in ablation volumes with consistent fiber configurations. Consequently, a prediction model is needed for the safe application of FLA in treating PCa. Objective This study aimed to evaluate the reproducibility of FLA–induced temperature profiles in controlled ex vivo experiments using clinical laser treatment protocols. Additionally, it sought to examine the effectiveness of the CEM43 model in predicting the zone of irreversible damage (ZID) and to compare these findings with outcomes derived from the Arrhenius model. Methods Freshly excised postmortem human prostate and porcine liver specimens were used for controlled ex vivo ablation. Tissues were secured in a Perspex sample holder for precise placement of the laser fiber and thermocouples. FLA was conducted with a 1064‐nm Nd:YAG laser at 3 W in continuous‐wave mode for 10 min. Pre– and post–FLA 3D T1‐weighted 7 T MRI scans were obtained to assess the treatment area. Whole‐mount hematoxylin and eosin histological slides were prepared and digitized. On histology, the ZID was defined as the total of vaporized, carbonized, and coagulated tissue. A 2D thermal development map was created from temperature data, using bi‐cubic interpolation. The cumulative equivalent thermal isoeffect dose at 43°C in minutes (CEM43) model was applied to predict the ZID, with 240 equivalent minutes (240‐CEM43) used as the damage threshold. Additionally, the Arrhenius thermal model was used for comparison of CEM43 results. Predicted ZIDs were compared to MRI and histology. Results FLA treatment was performed on ex vivo human prostate samples (n = 2) and porcine liver specimens (n = 5). For human prostate tissue, FLA did not result in an identifiable ZID upon histological macroscopic examination or a lesion on MRI. Ex vivo porcine liver samples showed a clearly demarcated oval‐shaped hyperintense lesion surrounding the laser fiber tip on post–FLA MRI. The MRI lesion (range 1.6–2.1 cm2) corresponded with the shape and location of the ZID on histology, but was smaller (median 1.7 vs. 3.2, p = 0.02). Histological examination of porcine liver samples revealed ZIDs ranging from 2.1 to 4.1 cm2, whereas 240‐CEM43–predicted ZIDs ranged from 3.3 to 3.8 cm2. Although the median 240‐CEM43–predicted ZID was not significantly larger than the histology ZID (3.8 vs. 3.2 cm2, p = 0.22), it tended to overpredict the histological results in most experiments. The median Arrhenius‐predicted ZID was similar to the histological ZID (3.2 vs. 3.2 cm2, p = 0.56), but varied in size when comparing individual experiments (range 2.5–3.2 cm2). Conclusion FLA on ex vivo human prostate showed no thermal damage on histopathology or MRI. Ex vivo porcine liver FLA resulted in identifiable ZID on histology and lesions on MRI. 240‐CEM43 generally overestimated the ZID and had less variability compared to histology. Results from the Arrhenius model were in better agreement with the histology findings, but still did not predict the individual FLA–induced histological thermal damage. Inter‐experiment ZID variability underlines the need for developing a more comprehensive predictive dosimetry model for FLA in PCa treatment.</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>39175158</pmid><doi>10.1002/lsm.23834</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0001-5759-3909</orcidid><orcidid>https://orcid.org/0000-0002-6892-8943</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0196-8092
ispartof Lasers in surgery and medicine, 2024-10, Vol.56 (8), p.723-733
issn 0196-8092
1096-9101
1096-9101
language eng
recordid cdi_proquest_miscellaneous_3096281615
source Wiley Online Library Journals
subjects Ablation
CEM43
Continuous fibers
Damage detection
Dosimetry
Equivalence
Experiments
focal laser ablation
Histology
Human performance
Laser ablation
Laser damage
Lasers
Lesions
Liver
Magnetic resonance imaging
Neodymium lasers
Prediction models
Predictive control
Prostate
Prostate cancer
Sample holders
Semiconductor lasers
Temperature profiles
Thermal analysis
thermal‐dose threshold
Thermocouples
YAG lasers
Yield point
title Outcomes of CEM43 in Predicting Thermal Damage Induced by Focal Laser Ablation in Controlled Ex Vivo Experiments: A Comparison to Histology and MRI
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-14T15%3A31%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Outcomes%20of%20CEM43%20in%20Predicting%20Thermal%20Damage%20Induced%20by%20Focal%20Laser%20Ablation%20in%20Controlled%20Ex%20Vivo%20Experiments:%20A%20Comparison%20to%20Histology%20and%20MRI&rft.jtitle=Lasers%20in%20surgery%20and%20medicine&rft.au=Bie,%20K.%20C.%20C.&rft.date=2024-10&rft.volume=56&rft.issue=8&rft.spage=723&rft.epage=733&rft.pages=723-733&rft.issn=0196-8092&rft.eissn=1096-9101&rft_id=info:doi/10.1002/lsm.23834&rft_dat=%3Cproquest_cross%3E3108519010%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3108519010&rft_id=info:pmid/39175158&rfr_iscdi=true